See All Slides - tctmd.com

Slides

Presentation Controversies and Advances 2025

Future Interventions for the Heart & Other Organs: “The Internet of the Human Body”

Presenter: Kalyanam Shivkumar

January 30, 2025

Presentation Controversies and Advances 2025

Cuffless blood pressure devices: Are they ready for prime time?

Presenter: Jennifer L. Cluett

January 30, 2025

Presentation Controversies and Advances 2025

Management of Hyperaldosteronism: Just Treat Medically to Cast a Wider Net!

Presenter: Richard J. Auchus

January 30, 2025

Presentation Controversies and Advances 2025

Management of Hyperaldosteronism: Adrenalectomy Has the Best Outcomes!

Presenter: Yufei Chen

January 30, 2025

Presentation Controversies and Advances 2025

FDA Approval for TTVI

Presenter: David J. Cohen

January 30, 2025

Presentation Controversies and Advances 2025

Percutaneous Mechanical Circulatory Support State of the Art in 2025

Presenter: Navin K. Kapur

January 30, 2025

Presentation Controversies and Advances 2025

Familial Chylomicronemia Syndrome: Emerging Treatment Technologies

Presenter: Peter P. Toth

January 30, 2025

Presentation

Test Slide #2

January 16, 2025

Presentation AHA 2024

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

Presenter: Steven E. Nissen

November 18, 2024

Presentation AHA 2024

Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial

Presenter: Marcely Gimenes Bonatto

November 18, 2024

Advertisement

Slides

Future Interventions for the Heart & Other Organs: “The Internet of the Human Body”

Cuffless blood pressure devices: Are they ready for prime time?

Management of Hyperaldosteronism: Just Treat Medically to Cast a Wider Net!

Management of Hyperaldosteronism: Adrenalectomy Has the Best Outcomes!

FDA Approval for TTVI

Percutaneous Mechanical Circulatory Support State of the Art in 2025

Familial Chylomicronemia Syndrome: Emerging Treatment Technologies

Test Slide #2

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content